News

Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...
A breakthrough has been made in weight-loss drugs after scientists discovered a new medication – known as TDP – that works ...
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost ...
Experts say there’s no evidence GLP-1s can be absorbed through the skin — and these patches don’t contain the FDA-approved ...
A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...
The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...
Explore more
The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.
New medicines have made weight loss easier than ever. But if you also want health and happiness, make these seven psychology ...
Stopping anti-obesity medications leads to significant weight regain, starting as early as eight weeks and stabilizing by six ...
A warning has now been issued after ‘GLP-1 weight-loss patches’ were spotted online amidst the surge in Mounjaro popularity.
Experts say people who take GLP-1 weight loss medications should stay hydrated, particularly when temperatures are high. The ...
CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.